1. Home
  2. KALV vs TIPT Comparison

KALV vs TIPT Comparison

Compare KALV & TIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$17.04

Market Cap

757.7M

Sector

Health Care

ML Signal

HOLD

Logo Tiptree Inc.

TIPT

Tiptree Inc.

HOLD

Current Price

$15.68

Market Cap

653.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
TIPT
Founded
N/A
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
757.7M
653.2M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
KALV
TIPT
Price
$17.04
$15.68
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$30.00
N/A
AVG Volume (30 Days)
761.7K
235.6K
Earning Date
05-09-2026
03-06-2026
Dividend Yield
N/A
1.53%
EPS Growth
N/A
N/A
EPS
N/A
0.76
Revenue
$50,000,000.00
$488,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$20.68
Revenue Growth
495.66
N/A
52 Week Low
$9.83
$15.59
52 Week High
$19.00
$27.38

Technical Indicators

Market Signals
Indicator
KALV
TIPT
Relative Strength Index (RSI) 55.56 33.14
Support Level $14.59 N/A
Resistance Level $17.30 $18.39
Average True Range (ATR) 1.10 0.44
MACD -0.05 -0.06
Stochastic Oscillator 53.88 11.35

Price Performance

Historical Comparison
KALV
TIPT

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About TIPT Tiptree Inc.

Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.

Share on Social Networks: